193 related articles for article (PubMed ID: 2661588)
1. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.
Eidt JF; Allison P; Noble S; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
J Clin Invest; 1989 Jul; 84(1):18-27. PubMed ID: 2661588
[TBL] [Abstract][Full Text] [Related]
2. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
[TBL] [Abstract][Full Text] [Related]
3. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
[TBL] [Abstract][Full Text] [Related]
4. Thrombin is an important mediator of cyclic coronary blood flow variations due to platelet aggregation in stenosed canine coronary arteries.
Eidt JF; Allison P; Noble S; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
Trans Assoc Am Physicians; 1988; 101():125-36. PubMed ID: 3269674
[No Abstract] [Full Text] [Related]
5. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries.
Yao SK; Ober JC; Gonenne A; Clubb FJ; Krishnaswami A; Ferguson JJ; Anderson HV; Gorecki M; Buja LM; Willerson JT
Circ Res; 1993 Nov; 73(5):952-67. PubMed ID: 8403265
[TBL] [Abstract][Full Text] [Related]
6. Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.
Willerson JT; Yao SK; McNatt J; Cui K; Anderson HV; Swensen C; Ostro M; Buja LM
Circulation; 1994 Apr; 89(4):1786-91. PubMed ID: 8149544
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A2 and serotonin mediate coronary blood flow reductions in unsedated dogs.
Eidt JF; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
Am J Physiol; 1989 Sep; 257(3 Pt 2):H873-82. PubMed ID: 2782444
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.
Duval N; Lunven C; O'Brien DP; Grosset A; O'Connor SE; Berry CN
Br J Pharmacol; 1996 Jun; 118(3):727-33. PubMed ID: 8762100
[TBL] [Abstract][Full Text] [Related]
9. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
10. Cyclic flow variations in a conscious dog model of coronary artery stenosis and endothelial injury correlate with acute ischemic heart disease syndromes in humans.
Ikeda H; Koga Y; Kuwano K; Nakayama H; Ueno T; Yoshida N; Adachi K; Park IS; Toshima H
J Am Coll Cardiol; 1993 Mar; 21(4):1008-17. PubMed ID: 8450149
[TBL] [Abstract][Full Text] [Related]
11. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
Beaughard M; Brasset M; John G; Massingham R
J Cardiovasc Pharmacol; 1995 Oct; 26(4):577-83. PubMed ID: 8569218
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
[TBL] [Abstract][Full Text] [Related]
13. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.
Ashton JH; Ogletree ML; Michel IM; Golino P; McNatt JM; Taylor AL; Raheja S; Schmitz J; Buja LM; Campbell WB
Circulation; 1987 Oct; 76(4):952-9. PubMed ID: 3652429
[TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidase mediates cyclic flow variations in a canine model of coronary arterial thrombosis.
Kuwano K; Ikeda H; Oda T; Nakayama H; Koga Y; Toshima H; Imaizumi T
Am J Physiol; 1996 Jun; 270(6 Pt 2):H1993-9. PubMed ID: 8764249
[TBL] [Abstract][Full Text] [Related]
15. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
[TBL] [Abstract][Full Text] [Related]
16. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
Yao SK; Benedict CR; Rosolowsky M; McNatt J; Falinska B; Campbell WB; Buja LM; Willerson JT
J Mol Cell Cardiol; 1991 Apr; 23(4):473-82. PubMed ID: 1942081
[TBL] [Abstract][Full Text] [Related]
17. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
[TBL] [Abstract][Full Text] [Related]
18. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.
Golino P; Buja LM; Yao SK; McNatt J; Willerson JT
J Am Coll Cardiol; 1990 Mar; 15(3):718-26. PubMed ID: 2105989
[TBL] [Abstract][Full Text] [Related]
19. Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury.
Eidt JF; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
J Clin Invest; 1989 Aug; 84(2):517-27. PubMed ID: 2760199
[TBL] [Abstract][Full Text] [Related]
20. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries.
Anderson HV; McNatt J; Clubb FJ; Herman M; Maffrand JP; DeClerck F; Ahn C; Buja LM; Willerson JT
Circulation; 2001 Nov; 104(19):2331-7. PubMed ID: 11696474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
